The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

UK MHRA asks for views on proposed guidance to support the safe regulation of new personalised cancer therapies: United Kingdom Tuesday, February 4, 2025, 11:00 Hrs [IST] The Medi ...

Breast cancer cases in Americans under 45 years old dramatically increased after the introduction of mRNA COVID-19 vaccines, from approximately 26,000 in 2019-2022 to 297,000 in 2023, a nearly 1,000% ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

Although formulation of mRNA vaccines and sophisticated delivery methods are important for advancing therapeutic vaccination (e.g., against cancer), such approaches will not be appropriate when it ...

Beyond vaccines, pharma is looking to develop mRNA vaccines to treat diseases requiring protein expression, such as cancer. Cancer has proved to be a graveyard for vaccine developers, however ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...